2019 ലെ മികച്ച ഇക്വിറ്റി മ്യൂച്വൽ ഫണ്ടുകൾ

Updated on October 15, 2025 , 728 views

ഇക്വിറ്റി ഫണ്ടുകൾ വിവിധ കമ്പനികളുടെ ഇക്വിറ്റി, ഇക്വിറ്റി സംബന്ധിയായ ഉപകരണങ്ങളിൽ നിക്ഷേപിച്ച ഫണ്ട് പണം നിക്ഷേപിക്കുന്നവരാണ്. മിതമായതും ഉയർന്നതുമായ ആളുകൾക്ക് ദീർഘകാല നിക്ഷേപ ഓപ്ഷനായി ഇക്വിറ്റി ഫണ്ടുകൾ കണക്കാക്കപ്പെടുന്നുഅപകടസാധ്യത വിശപ്പ്. ഇക്വിറ്റി ഫണ്ടുകളുടെ വിവിധ വിഭാഗങ്ങൾ ഉൾപ്പെടുന്നുവലിയ ക്യാപ് ഫണ്ടുകൾ,മിഡ് ക്യാപ് ഫണ്ടുകൾ,ചെറിയ ക്യാപ് ഫണ്ടുകൾ,ELSS, ഇത്യാദി. 2019 ൽ, ഇക്വിറ്റി മാർക്കറ്റുകളിൽ ഒരു ഉയർച്ചയുണ്ടായി, ഇക്വിറ്റി ഫണ്ട് വിഭാഗങ്ങളിൽ ഭൂരിഭാഗവും മികച്ച പ്രകടനം കാഴ്ചവച്ചു. ഈ ഫണ്ടുകളുടെ പ്രകടനം വ്യവസായ പ്രകടനം, കമ്പനി പ്രകടനം, കമ്പനികളുടെ വരുമാനവും ലാഭവും, അതിന്റെ ഭാവി സാധ്യതകൾ തുടങ്ങിയ നിരവധി മാക്രോ, മൈക്രോ ഇക്കണോമിക് പാരാമീറ്ററുകളെ ആശ്രയിച്ചിരിക്കുന്നു. മുകളിലുംമികച്ച ഇക്വിറ്റി ഫണ്ടുകൾ 2019 വർഷത്തിൽ ഇനിപ്പറയുന്നവയാണ്.

Ready to Invest?
Talk to our investment specialist

പ്രകടനത്തെ അടിസ്ഥാനമാക്കി 2019 ലെ മികച്ച 10 ഇക്വിറ്റി മ്യൂച്വൽ ഫണ്ടുകൾ

Fund	NAV	Net Assets (Cr)	2024 (%)	2023 (%)	2022 (%)	2021 (%)	2020 (%)
Motilal Oswal Midcap 30 Fund Growth	₹104.704 ↓ -0.40	₹34,780	57.1	41.7	10.7	55.8	9.3
LIC MF Infrastructure Fund Growth	₹50.0434 ↓ -0.08	₹995	47.8	44.4	7.9	46.6	-0.1
Motilal Oswal Long Term Equity Fund Growth	₹53.1996 ↓ -0.09	₹4,223	47.7	37	1.8	32.1	8.8
Motilal Oswal Multicap 35 Fund Growth	₹62.8975 ↓ -0.36	₹13,679	45.7	31	-3	15.3	10.3
Invesco India Mid Cap Fund Growth	₹185.49 ↓ -1.11	₹8,062	43.1	34.1	0.5	43.1	24.4
UTI Healthcare Fund Growth	₹292.918 ↑ 0.17	₹1,119	42.9	38.2	-12.3	19.1	67.4
SBI Healthcare Opportunities Fund Growth	₹435.752 ↑ 2.45	₹3,963	42.2	38.2	-6	20.1	65.8
TATA India Pharma & Healthcare Fund Growth	₹30.9955 ↑ 0.17	₹1,309	40.4	36.6	-8	19.1	64.4
IDBI Small Cap Fund Growth	₹30.323 ↓ -0.16	₹604	40	33.4	2.4	64.7	19
Bandhan Infrastructure Fund Growth	₹49.783 ↓ -0.13	₹1,613	39.3	50.3	1.7	64.8	6.3
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 17 Oct 25

Research Highlights & Commentary of 10 Funds showcased

Commentary	Motilal Oswal Midcap 30 Fund	LIC MF Infrastructure Fund	Motilal Oswal Long Term Equity Fund	Motilal Oswal Multicap 35 Fund	Invesco India Mid Cap Fund	UTI Healthcare Fund	SBI Healthcare Opportunities Fund	TATA India Pharma & Healthcare Fund	IDBI Small Cap Fund	Bandhan Infrastructure Fund
Point 1	Highest AUM (₹34,780 Cr).	Bottom quartile AUM (₹995 Cr).	Upper mid AUM (₹4,223 Cr).	Top quartile AUM (₹13,679 Cr).	Upper mid AUM (₹8,062 Cr).	Bottom quartile AUM (₹1,119 Cr).	Upper mid AUM (₹3,963 Cr).	Lower mid AUM (₹1,309 Cr).	Bottom quartile AUM (₹604 Cr).	Lower mid AUM (₹1,613 Cr).
Point 2	Established history (11+ yrs).	Established history (17+ yrs).	Established history (10+ yrs).	Established history (11+ yrs).	Established history (18+ yrs).	Oldest track record among peers (26 yrs).	Established history (20+ yrs).	Established history (9+ yrs).	Established history (8+ yrs).	Established history (14+ yrs).
Point 3	Rating: 3★ (upper mid).	Not Rated.	Not Rated.	Top rated.	Rating: 2★ (upper mid).	Rating: 1★ (lower mid).	Rating: 2★ (upper mid).	Not Rated.	Not Rated.	Rating: 5★ (top quartile).
Point 4	Risk profile: Moderately High.	Risk profile: High.	Risk profile: Moderately High.	Risk profile: Moderately High.	Risk profile: Moderately High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: Moderately High.	Risk profile: High.
Point 5	5Y return: 33.66% (top quartile).	5Y return: 31.58% (upper mid).	5Y return: 26.09% (lower mid).	5Y return: 19.51% (lower mid).	5Y return: 28.47% (upper mid).	5Y return: 17.58% (bottom quartile).	5Y return: 19.36% (bottom quartile).	5Y return: 17.80% (bottom quartile).	5Y return: 27.67% (upper mid).	5Y return: 33.39% (top quartile).
Point 6	3Y return: 26.87% (upper mid).	3Y return: 28.70% (top quartile).	3Y return: 26.60% (upper mid).	3Y return: 22.84% (bottom quartile).	3Y return: 28.83% (top quartile).	3Y return: 24.94% (lower mid).	3Y return: 25.73% (lower mid).	3Y return: 22.90% (bottom quartile).	3Y return: 17.82% (bottom quartile).	3Y return: 27.74% (upper mid).
Point 7	1Y return: -2.92% (lower mid).	1Y return: -3.50% (bottom quartile).	1Y return: -3.19% (lower mid).	1Y return: 0.64% (upper mid).	1Y return: 9.75% (top quartile).	1Y return: 1.95% (upper mid).	1Y return: 3.00% (top quartile).	1Y return: -0.05% (upper mid).	1Y return: -10.44% (bottom quartile).	1Y return: -8.68% (bottom quartile).
Point 8	Alpha: 4.99 (upper mid).	Alpha: -1.71 (bottom quartile).	Alpha: 7.18 (top quartile).	Alpha: 9.76 (top quartile).	Alpha: 0.00 (lower mid).	Alpha: 0.79 (lower mid).	Alpha: 2.04 (upper mid).	Alpha: 3.78 (upper mid).	Alpha: -4.61 (bottom quartile).	Alpha: 0.00 (bottom quartile).
Point 9	Sharpe: -0.18 (upper mid).	Sharpe: -0.46 (bottom quartile).	Sharpe: -0.26 (lower mid).	Sharpe: -0.06 (upper mid).	Sharpe: 0.14 (top quartile).	Sharpe: -0.15 (upper mid).	Sharpe: -0.05 (top quartile).	Sharpe: -0.39 (lower mid).	Sharpe: -0.70 (bottom quartile).	Sharpe: -0.71 (bottom quartile).
Point 10	Information ratio: 0.57 (upper mid).	Information ratio: 0.34 (lower mid).	Information ratio: 0.80 (top quartile).	Information ratio: 0.79 (top quartile).	Information ratio: 0.00 (bottom quartile).	Information ratio: 0.10 (lower mid).	Information ratio: 0.38 (upper mid).	Information ratio: 0.78 (upper mid).	Information ratio: -0.82 (bottom quartile).	Information ratio: 0.00 (bottom quartile).

Motilal Oswal Midcap 30 Fund

Highest AUM (₹34,780 Cr).
Established history (11+ yrs).
Rating: 3★ (upper mid).
Risk profile: Moderately High.
5Y return: 33.66% (top quartile).
3Y return: 26.87% (upper mid).
1Y return: -2.92% (lower mid).
Alpha: 4.99 (upper mid).
Sharpe: -0.18 (upper mid).
Information ratio: 0.57 (upper mid).

LIC MF Infrastructure Fund

Bottom quartile AUM (₹995 Cr).
Established history (17+ yrs).
Not Rated.
Risk profile: High.
5Y return: 31.58% (upper mid).
3Y return: 28.70% (top quartile).
1Y return: -3.50% (bottom quartile).
Alpha: -1.71 (bottom quartile).
Sharpe: -0.46 (bottom quartile).
Information ratio: 0.34 (lower mid).

Motilal Oswal Long Term Equity Fund

Upper mid AUM (₹4,223 Cr).
Established history (10+ yrs).
Not Rated.
Risk profile: Moderately High.
5Y return: 26.09% (lower mid).
3Y return: 26.60% (upper mid).
1Y return: -3.19% (lower mid).
Alpha: 7.18 (top quartile).
Sharpe: -0.26 (lower mid).
Information ratio: 0.80 (top quartile).

Motilal Oswal Multicap 35 Fund

Top quartile AUM (₹13,679 Cr).
Established history (11+ yrs).
Top rated.
Risk profile: Moderately High.
5Y return: 19.51% (lower mid).
3Y return: 22.84% (bottom quartile).
1Y return: 0.64% (upper mid).
Alpha: 9.76 (top quartile).
Sharpe: -0.06 (upper mid).
Information ratio: 0.79 (top quartile).

Invesco India Mid Cap Fund

Upper mid AUM (₹8,062 Cr).
Established history (18+ yrs).
Rating: 2★ (upper mid).
Risk profile: Moderately High.
5Y return: 28.47% (upper mid).
3Y return: 28.83% (top quartile).
1Y return: 9.75% (top quartile).
Alpha: 0.00 (lower mid).
Sharpe: 0.14 (top quartile).
Information ratio: 0.00 (bottom quartile).

UTI Healthcare Fund

Bottom quartile AUM (₹1,119 Cr).
Oldest track record among peers (26 yrs).
Rating: 1★ (lower mid).
Risk profile: High.
5Y return: 17.58% (bottom quartile).
3Y return: 24.94% (lower mid).
1Y return: 1.95% (upper mid).
Alpha: 0.79 (lower mid).
Sharpe: -0.15 (upper mid).
Information ratio: 0.10 (lower mid).

SBI Healthcare Opportunities Fund

Upper mid AUM (₹3,963 Cr).
Established history (20+ yrs).
Rating: 2★ (upper mid).
Risk profile: High.
5Y return: 19.36% (bottom quartile).
3Y return: 25.73% (lower mid).
1Y return: 3.00% (top quartile).
Alpha: 2.04 (upper mid).
Sharpe: -0.05 (top quartile).
Information ratio: 0.38 (upper mid).

TATA India Pharma & Healthcare Fund

Lower mid AUM (₹1,309 Cr).
Established history (9+ yrs).
Not Rated.
Risk profile: High.
5Y return: 17.80% (bottom quartile).
3Y return: 22.90% (bottom quartile).
1Y return: -0.05% (upper mid).
Alpha: 3.78 (upper mid).
Sharpe: -0.39 (lower mid).
Information ratio: 0.78 (upper mid).

IDBI Small Cap Fund

Bottom quartile AUM (₹604 Cr).
Established history (8+ yrs).
Not Rated.
Risk profile: Moderately High.
5Y return: 27.67% (upper mid).
3Y return: 17.82% (bottom quartile).
1Y return: -10.44% (bottom quartile).
Alpha: -4.61 (bottom quartile).
Sharpe: -0.70 (bottom quartile).
Information ratio: -0.82 (bottom quartile).

Bandhan Infrastructure Fund

Lower mid AUM (₹1,613 Cr).
Established history (14+ yrs).
Rating: 5★ (top quartile).
Risk profile: High.
5Y return: 33.39% (top quartile).
3Y return: 27.74% (upper mid).
1Y return: -8.68% (bottom quartile).
Alpha: 0.00 (bottom quartile).
Sharpe: -0.71 (bottom quartile).
Information ratio: 0.00 (bottom quartile).

2019 ലെ മികച്ചതും മികച്ചതുമായ ഇക്വിറ്റി മ്യൂച്വൽ ഫണ്ടുകൾ

1. Motilal Oswal Midcap 30 Fund

(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund)

The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Research Highlights for Motilal Oswal Midcap 30 Fund

Highest AUM (₹34,780 Cr).
Established history (11+ yrs).
Rating: 3★ (upper mid).
Risk profile: Moderately High.
5Y return: 33.66% (top quartile).
3Y return: 26.87% (upper mid).
1Y return: -2.92% (lower mid).
Alpha: 4.99 (upper mid).
Sharpe: -0.18 (upper mid).
Information ratio: 0.57 (upper mid).
Higher exposure to Technology vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~97%).
Largest holding Dixon Technologies (India) Ltd (~10.1%).

Below is the key information for Motilal Oswal Midcap 30 Fund

Motilal Oswal Midcap 30 Fund Growth
Launch Date	24 Feb 14
NAV (17 Oct 25)	₹104.704 ↓ -0.40 (-0.38 %)
Net Assets (Cr)	₹34,780 on 31 Aug 25
Category	Equity - Mid Cap
AMC	Motilal Oswal Asset Management Co. Ltd
Rating	☆☆☆
Risk	Moderately High
Expense Ratio	1.56
Sharpe Ratio	-0.18
Information Ratio	0.57
Alpha Ratio	4.99
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Sep 20	₹10,000
30 Sep 21	₹16,771
30 Sep 22	₹20,631
30 Sep 23	₹24,973
30 Sep 24	₹42,904
30 Sep 25	₹39,390

Motilal Oswal Midcap 30 Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹689,048.
Net Profit of ₹389,048 Invest Now

Returns for Motilal Oswal Midcap 30 Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 17 Oct 25

Duration	Returns
1 Month	-1.5%
3 Month	1.3%
6 Month	15.2%
1 Year	-2.9%
3 Year	26.9%
5 Year	33.7%
10 Year
15 Year
Since launch	22.3%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	57.1%
2023	41.7%
2022	10.7%
2021	55.8%
2020	9.3%
2019	9.7%
2018	-12.7%
2017	30.8%
2016	5.2%
2015	16.5%

Fund Manager information for Motilal Oswal Midcap 30 Fund

Name	Since	Tenure
Ajay Khandelwal	1 Oct 24	0.92 Yr.
Niket Shah	1 Jul 20	5.17 Yr.
Rakesh Shetty	22 Nov 22	2.78 Yr.
Sunil Sawant	1 Jul 24	1.17 Yr.

Data below for Motilal Oswal Midcap 30 Fund as on 31 Aug 25

Equity Sector Allocation

Sector	Value
Technology	37.96%
Consumer Cyclical	26.86%
Industrials	20.24%
Communication Services	3.34%
Health Care	3.21%
Financial Services	3.2%
Real Estate	2.58%

Asset Allocation

Asset Class	Value
Cash	2.61%
Equity	97.39%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Dixon Technologies (India) Ltd (Technology) Equity, Since 31 Mar 23 \| DIXON	10%	₹3,505 Cr	2,099,999
Coforge Ltd (Technology) Equity, Since 31 Mar 23 \| COFORGE	10%	₹3,405 Cr	19,750,000 ↑ 1,749,950
Trent Ltd (Consumer Cyclical) Equity, Since 30 Nov 24 \| TRENT	9%	₹3,179 Cr	6,000,000 ↑ 750,000
Eternal Ltd (Consumer Cyclical) Equity, Since 31 Aug 25 \| 543320	9%	₹3,140 Cr	100,000,000 ↑ 100,000,000
Kalyan Jewellers India Ltd (Consumer Cyclical) Equity, Since 29 Feb 24 \| KALYANKJIL	9%	₹3,025 Cr	60,000,000 ↑ 9,923,760
One97 Communications Ltd (Technology) Equity, Since 30 Sep 24 \| 543396	9%	₹3,018 Cr	25,000,000 ↑ 11,130,003
Persistent Systems Ltd (Technology) Equity, Since 31 Jan 23 \| PERSISTENT	8%	₹2,918 Cr	5,500,000 ↑ 99,995
Polycab India Ltd (Industrials) Equity, Since 30 Sep 23 \| POLYCAB	6%	₹2,163 Cr	3,050,000 ↑ 300,000
KEI Industries Ltd (Industrials) Equity, Since 30 Nov 24 \| KEI	4%	₹1,429 Cr	3,750,000 ↑ 250,000
Kaynes Technology India Ltd (Industrials) Equity, Since 30 Jun 25 \| KAYNES	4%	₹1,286 Cr	2,100,000 ↑ 153,298

2. LIC MF Infrastructure Fund

The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector.

Research Highlights for LIC MF Infrastructure Fund

Bottom quartile AUM (₹995 Cr).
Established history (17+ yrs).
Not Rated.
Risk profile: High.
5Y return: 31.58% (upper mid).
3Y return: 28.70% (top quartile).
1Y return: -3.50% (bottom quartile).
Alpha: -1.71 (bottom quartile).
Sharpe: -0.46 (bottom quartile).
Information ratio: 0.34 (lower mid).
Higher exposure to Industrials vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~97%).
High-quality debt (AAA/AA ~100%).
Largest holding Shakti Pumps (India) Ltd (~5.6%).

Below is the key information for LIC MF Infrastructure Fund

LIC MF Infrastructure Fund Growth
Launch Date	29 Feb 08
NAV (17 Oct 25)	₹50.0434 ↓ -0.08 (-0.16 %)
Net Assets (Cr)	₹995 on 31 Aug 25
Category	Equity - Sectoral
AMC	LIC Mutual Fund Asset Mgmt Co Ltd
Rating	Not Rated
Risk	High
Expense Ratio	2.21
Sharpe Ratio	-0.47
Information Ratio	0.34
Alpha Ratio	-1.71
Min Investment	5,000
Min SIP Investment	1,000
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Sep 20	₹10,000
30 Sep 21	₹17,349
30 Sep 22	₹19,152
30 Sep 23	₹24,311
30 Sep 24	₹42,112
30 Sep 25	₹39,703

LIC MF Infrastructure Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹657,502.
Net Profit of ₹357,502 Invest Now

Returns for LIC MF Infrastructure Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 17 Oct 25

Duration	Returns
1 Month	-1.3%
3 Month	-1.5%
6 Month	14.9%
1 Year	-3.5%
3 Year	28.7%
5 Year	31.6%
10 Year
15 Year
Since launch	9.6%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	47.8%
2023	44.4%
2022	7.9%
2021	46.6%
2020	-0.1%
2019	13.3%
2018	-14.6%
2017	42.2%
2016	-2.2%
2015	-6.2%

Fund Manager information for LIC MF Infrastructure Fund

Name	Since	Tenure
Yogesh Patil	18 Sep 20	4.96 Yr.
Mahesh Bendre	1 Jul 24	1.17 Yr.

Data below for LIC MF Infrastructure Fund as on 31 Aug 25

Equity Sector Allocation

Sector	Value
Industrials	50.96%
Basic Materials	9.62%
Financial Services	7.78%
Consumer Cyclical	6.93%
Utility	5.82%
Technology	4.2%
Health Care	4.07%
Real Estate	3.47%
Communication Services	2.94%
Energy	0.9%

Asset Allocation

Asset Class	Value
Cash	3.31%
Equity	96.69%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Shakti Pumps (India) Ltd (Industrials) Equity, Since 31 Mar 24 \| SHAKTIPUMP	6%	₹56 Cr	693,857
Larsen & Toubro Ltd (Industrials) Equity, Since 30 Apr 09 \| LT	4%	₹39 Cr	109,584
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Jun 25 \| APOLLOHOSP	4%	₹36 Cr	46,843
Afcons Infrastructure Ltd (Industrials) Equity, Since 31 Oct 24 \| AFCONS	3%	₹32 Cr	769,765
REC Ltd (Financial Services) Equity, Since 31 Jul 23 \| RECLTD	3%	₹32 Cr	911,009
Schneider Electric Infrastructure Ltd (Industrials) Equity, Since 31 Dec 23 \| SCHNEIDER	3%	₹27 Cr	319,302
Avalon Technologies Ltd (Technology) Equity, Since 31 Jul 23 \| AVALON	3%	₹26 Cr	310,615
Cummins India Ltd (Industrials) Equity, Since 31 May 21 \| CUMMINSIND	3%	₹26 Cr	67,407
Garware Hi-Tech Films Ltd (Basic Materials) Equity, Since 31 Aug 23 \| 500655	3%	₹25 Cr	94,287
Mahindra Lifespace Developers Ltd (Real Estate) Equity, Since 30 Jun 24 \| MAHLIFE	2%	₹23 Cr	666,245

3. Motilal Oswal Long Term Equity Fund

(Erstwhile Motilal Oswal MOSt Focused Long Term Fund)

The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Research Highlights for Motilal Oswal Long Term Equity Fund

Upper mid AUM (₹4,223 Cr).
Established history (10+ yrs).
Not Rated.
Risk profile: Moderately High.
5Y return: 26.09% (lower mid).
3Y return: 26.60% (upper mid).
1Y return: -3.19% (lower mid).
Alpha: 7.18 (top quartile).
Sharpe: -0.26 (lower mid).
Information ratio: 0.80 (top quartile).
Top sector: Industrials.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~98%).
Largest holding Eternal Ltd (~6.7%).

Below is the key information for Motilal Oswal Long Term Equity Fund

Motilal Oswal Long Term Equity Fund Growth
Launch Date	21 Jan 15
NAV (17 Oct 25)	₹53.1996 ↓ -0.09 (-0.16 %)
Net Assets (Cr)	₹4,223 on 31 Aug 25
Category	Equity - ELSS
AMC	Motilal Oswal Asset Management Co. Ltd
Rating	Not Rated
Risk	Moderately High
Expense Ratio	1.65
Sharpe Ratio	-0.26
Information Ratio	0.8
Alpha Ratio	7.18
Min Investment	500
Min SIP Investment	500
Exit Load	NIL

Growth of 10,000 investment over the years.

Date	Value
30 Sep 20	₹10,000
30 Sep 21	₹16,651
30 Sep 22	₹16,046
30 Sep 23	₹20,191
30 Sep 24	₹33,630
30 Sep 25	₹31,553

Motilal Oswal Long Term Equity Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹584,107.
Net Profit of ₹284,107 Invest Now

Returns for Motilal Oswal Long Term Equity Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 17 Oct 25

Duration	Returns
1 Month	-0.6%
3 Month	0.2%
6 Month	16.1%
1 Year	-3.2%
3 Year	26.6%
5 Year	26.1%
10 Year
15 Year
Since launch	16.8%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	47.7%
2023	37%
2022	1.8%
2021	32.1%
2020	8.8%
2019	13.2%
2018	-8.7%
2017	44%
2016	12.5%
2015

Fund Manager information for Motilal Oswal Long Term Equity Fund

Name	Since	Tenure
Ajay Khandelwal	11 Dec 23	1.73 Yr.
Rakesh Shetty	22 Nov 22	2.78 Yr.
Atul Mehra	1 Oct 24	0.92 Yr.

Data below for Motilal Oswal Long Term Equity Fund as on 31 Aug 25

Equity Sector Allocation

Sector	Value
Industrials	31.75%
Financial Services	18.72%
Consumer Cyclical	18.07%
Technology	13.51%
Basic Materials	5.57%
Real Estate	4.35%
Health Care	3.36%
Communication Services	1.59%
Consumer Defensive	1.34%

Asset Allocation

Asset Class	Value
Cash	1.75%
Equity	98.25%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Eternal Ltd (Consumer Cyclical) Equity, Since 31 Oct 23 \| 543320	7%	₹282 Cr	8,970,581
Multi Commodity Exchange of India Ltd (Financial Services) Equity, Since 29 Feb 24 \| MCX	5%	₹192 Cr	259,208 ↑ 10,770
Prestige Estates Projects Ltd (Real Estate) Equity, Since 31 Oct 23 \| PRESTIGE	4%	₹184 Cr	1,176,224 ↓ -55,632
Kaynes Technology India Ltd (Industrials) Equity, Since 30 Jun 23 \| KAYNES	4%	₹177 Cr	289,593
Waaree Energies Ltd (Technology) Equity, Since 31 Oct 24 \| 544277	4%	₹176 Cr	516,106 ↑ 29,061
Amber Enterprises India Ltd Ordinary Shares (Consumer Cyclical) Equity, Since 31 Mar 24 \| AMBER	4%	₹175 Cr	240,350
One97 Communications Ltd (Technology) Equity, Since 30 Jun 25 \| 543396	4%	₹152 Cr	1,256,967 ↑ 285,421
Bharat Dynamics Ltd Ordinary Shares (Industrials) Equity, Since 31 Dec 23 \| BDL	3%	₹147 Cr	1,022,957 ↓ -33,358
Gujarat Fluorochemicals Ltd Ordinary Shares (Basic Materials) Equity, Since 28 Feb 23 \| FLUOROCHEM	3%	₹147 Cr	430,073
Piramal Enterprises Ltd (Financial Services) Equity, Since 31 Jul 24 \| PEL	3%	₹143 Cr	1,279,233 ↑ 110,849

4. Motilal Oswal Multicap 35 Fund

(Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund)

The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Research Highlights for Motilal Oswal Multicap 35 Fund

Top quartile AUM (₹13,679 Cr).
Established history (11+ yrs).
Top rated.
Risk profile: Moderately High.
5Y return: 19.51% (lower mid).
3Y return: 22.84% (bottom quartile).
1Y return: 0.64% (upper mid).
Alpha: 9.76 (top quartile).
Sharpe: -0.06 (upper mid).
Information ratio: 0.79 (top quartile).
Higher exposure to Technology vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~98%).
Largest holding Polycab India Ltd (~10.4%).

Below is the key information for Motilal Oswal Multicap 35 Fund

Motilal Oswal Multicap 35 Fund Growth
Launch Date	28 Apr 14
NAV (17 Oct 25)	₹62.8975 ↓ -0.36 (-0.57 %)
Net Assets (Cr)	₹13,679 on 31 Aug 25
Category	Equity - Multi Cap
AMC	Motilal Oswal Asset Management Co. Ltd
Rating	☆☆☆☆☆
Risk	Moderately High
Expense Ratio	1.77
Sharpe Ratio	-0.06
Information Ratio	0.79
Alpha Ratio	9.76
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Sep 20	₹10,000
30 Sep 21	₹14,224
30 Sep 22	₹13,477
30 Sep 23	₹15,455
30 Sep 24	₹25,165
30 Sep 25	₹23,797

Motilal Oswal Multicap 35 Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹493,520.
Net Profit of ₹193,520 Invest Now

Returns for Motilal Oswal Multicap 35 Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 17 Oct 25

Duration	Returns
1 Month	-1.7%
3 Month	0.2%
6 Month	11.6%
1 Year	0.6%
3 Year	22.8%
5 Year	19.5%
10 Year
15 Year
Since launch	17.4%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	45.7%
2023	31%
2022	-3%
2021	15.3%
2020	10.3%
2019	7.9%
2018	-7.8%
2017	43.1%
2016	8.5%
2015	14.6%

Fund Manager information for Motilal Oswal Multicap 35 Fund

Name	Since	Tenure
Ajay Khandelwal	1 Oct 24	0.92 Yr.
Niket Shah	1 Jul 22	3.17 Yr.
Rakesh Shetty	22 Nov 22	2.78 Yr.
Atul Mehra	1 Oct 24	0.92 Yr.
Sunil Sawant	1 Jul 24	1.17 Yr.

Data below for Motilal Oswal Multicap 35 Fund as on 31 Aug 25

Equity Sector Allocation

Sector	Value
Technology	32.01%
Consumer Cyclical	25.1%
Industrials	20.77%
Financial Services	9.8%
Utility	6.17%
Communication Services	2.9%
Health Care	1.69%

Asset Allocation

Asset Class	Value
Cash	1.57%
Equity	98.43%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Polycab India Ltd (Industrials) Equity, Since 31 Jan 24 \| POLYCAB	10%	₹1,418 Cr	2,000,000
Coforge Ltd (Technology) Equity, Since 31 May 23 \| COFORGE	10%	₹1,379 Cr	8,000,000 ↓ -5,911
Dixon Technologies (India) Ltd (Technology) Equity, Since 31 Mar 25 \| DIXON	10%	₹1,335 Cr	800,000
Persistent Systems Ltd (Technology) Equity, Since 31 Mar 23 \| PERSISTENT	10%	₹1,326 Cr	2,500,000 ↑ 200,000
Trent Ltd (Consumer Cyclical) Equity, Since 31 Jan 23 \| TRENT	10%	₹1,325 Cr	2,500,000 ↑ 500,000
Eternal Ltd (Consumer Cyclical) Equity, Since 31 May 25 \| 543320	8%	₹1,099 Cr	35,000,000 ↑ 32,866,603
Kalyan Jewellers India Ltd (Consumer Cyclical) Equity, Since 30 Sep 23 \| KALYANKJIL	7%	₹1,008 Cr	20,000,000
CG Power & Industrial Solutions Ltd (Industrials) Equity, Since 31 Jan 25 \| CGPOWER	6%	₹868 Cr	12,500,000 ↓ -999,862
Siemens Energy India Ltd (Utilities) Equity, Since 30 Jun 25 \| ENRIN	6%	₹844 Cr	2,500,000
Cholamandalam Investment and Finance Co Ltd (Financial Services) Equity, Since 31 Mar 23 \| CHOLAFIN	6%	₹835 Cr	5,877,500 ↑ 877,500

5. Invesco India Mid Cap Fund

The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved.

Research Highlights for Invesco India Mid Cap Fund

Upper mid AUM (₹8,062 Cr).
Established history (18+ yrs).
Rating: 2★ (upper mid).
Risk profile: Moderately High.
5Y return: 28.47% (upper mid).
3Y return: 28.83% (top quartile).
1Y return: 9.75% (top quartile).
Alpha: 0.00 (lower mid).
Sharpe: 0.14 (top quartile).
Information ratio: 0.00 (bottom quartile).
Higher exposure to Financial Services vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~99%).
Largest holding Swiggy Ltd (~5.0%).

Below is the key information for Invesco India Mid Cap Fund

Invesco India Mid Cap Fund Growth
Launch Date	19 Apr 07
NAV (17 Oct 25)	₹185.49 ↓ -1.11 (-0.59 %)
Net Assets (Cr)	₹8,062 on 31 Aug 25
Category	Equity - Mid Cap
AMC	Invesco Asset Management (India) Private Ltd
Rating	☆☆
Risk	Moderately High
Expense Ratio	1.82
Sharpe Ratio	0.14
Information Ratio	0
Alpha Ratio	0
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Sep 20	₹10,000
30 Sep 21	₹15,993
30 Sep 22	₹16,218
30 Sep 23	₹20,052
30 Sep 24	₹32,068
30 Sep 25	₹32,954

Invesco India Mid Cap Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹612,552.
Net Profit of ₹312,552 Invest Now

Returns for Invesco India Mid Cap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 17 Oct 25

Duration	Returns
1 Month	0.8%
3 Month	1.2%
6 Month	20%
1 Year	9.8%
3 Year	28.8%
5 Year	28.5%
10 Year
15 Year
Since launch	17.1%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	43.1%
2023	34.1%
2022	0.5%
2021	43.1%
2020	24.4%
2019	3.8%
2018	-5.3%
2017	44.3%
2016	1.1%
2015	6.4%

Fund Manager information for Invesco India Mid Cap Fund

Name	Since	Tenure
Aditya Khemani	9 Nov 23	1.81 Yr.
Amit Ganatra	1 Sep 23	2 Yr.

Data below for Invesco India Mid Cap Fund as on 31 Aug 25

Equity Sector Allocation

Sector	Value
Financial Services	30.14%
Health Care	18.68%
Consumer Cyclical	17.28%
Industrials	11.33%
Real Estate	7.58%
Technology	7.55%
Basic Materials	5.07%
Communication Services	1.53%

Asset Allocation

Asset Class	Value
Cash	0.84%
Equity	99.16%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Swiggy Ltd (Consumer Cyclical) Equity, Since 30 Nov 24 \| SWIGGY	5%	₹400 Cr	9,763,728 ↑ 1,008,324
L&T Finance Ltd (Financial Services) Equity, Since 31 Dec 23 \| LTF	5%	₹366 Cr	16,854,973
Prestige Estates Projects Ltd (Real Estate) Equity, Since 30 Nov 23 \| PRESTIGE	4%	₹340 Cr	2,179,545 ↑ 147,923
Max Financial Services Ltd (Financial Services) Equity, Since 30 Nov 23 \| MFSL	4%	₹325 Cr	2,031,299 ↑ 14,403
Glenmark Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Mar 24 \| GLENMARK	4%	₹323 Cr	1,676,417
JK Cement Ltd (Basic Materials) Equity, Since 31 Oct 22 \| JKCEMENT	4%	₹322 Cr	463,277
BSE Ltd (Financial Services) Equity, Since 31 Dec 23 \| BSE	4%	₹318 Cr	1,519,233
Trent Ltd (Consumer Cyclical) Equity, Since 30 Apr 21 \| TRENT	4%	₹309 Cr	583,431 ↑ 142,280
The Federal Bank Ltd (Financial Services) Equity, Since 31 Oct 22 \| FEDERALBNK	3%	₹280 Cr	14,592,638
AU Small Finance Bank Ltd (Financial Services) Equity, Since 31 Jul 25 \| AUBANK	3%	₹280 Cr	3,893,254 ↑ 2,304,000

6. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

Research Highlights for UTI Healthcare Fund

Bottom quartile AUM (₹1,119 Cr).
Oldest track record among peers (26 yrs).
Rating: 1★ (lower mid).
Risk profile: High.
5Y return: 17.58% (bottom quartile).
3Y return: 24.94% (lower mid).
1Y return: 1.95% (upper mid).
Alpha: 0.79 (lower mid).
Sharpe: -0.15 (upper mid).
Information ratio: 0.10 (lower mid).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~99%).
Largest holding Sun Pharmaceuticals Industries Ltd (~9.4%).

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund Growth
Launch Date	28 Jun 99
NAV (17 Oct 25)	₹292.918 ↑ 0.17 (0.06 %)
Net Assets (Cr)	₹1,119 on 31 Aug 25
Category	Equity - Sectoral
AMC	UTI Asset Management Company Ltd
Rating	☆
Risk	High
Expense Ratio	2.26
Sharpe Ratio	-0.15
Information Ratio	0.1
Alpha Ratio	0.79
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Sep 20	₹10,000
30 Sep 21	₹13,129
30 Sep 22	₹11,561
30 Sep 23	₹14,305
30 Sep 24	₹22,319
30 Sep 25	₹21,898

UTI Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹470,047.
Net Profit of ₹170,047 Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 17 Oct 25

Duration	Returns
1 Month	-1%
3 Month	-1.2%
6 Month	9.3%
1 Year	1.9%
3 Year	24.9%
5 Year	17.6%
10 Year
15 Year
Since launch	14.9%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	42.9%
2023	38.2%
2022	-12.3%
2021	19.1%
2020	67.4%
2019	1.2%
2018	-7.5%
2017	6.2%
2016	-9.7%
2015	12.4%

Fund Manager information for UTI Healthcare Fund

Name	Since	Tenure
Kamal Gada	2 May 22	3.34 Yr.

Data below for UTI Healthcare Fund as on 31 Aug 25

Equity Sector Allocation

Sector	Value
Health Care	98.23%
Basic Materials	1.12%

Asset Allocation

Asset Class	Value
Cash	0.65%
Equity	99.35%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 06 \| SUNPHARMA	9%	₹105 Cr	661,016
Cipla Ltd (Healthcare) Equity, Since 31 Jan 03 \| CIPLA	6%	₹64 Cr	400,000
Ajanta Pharma Ltd (Healthcare) Equity, Since 31 Jul 17 \| AJANTPHARM	5%	₹60 Cr	242,673 ↑ 42,673
Lupin Ltd (Healthcare) Equity, Since 28 Feb 25 \| LUPIN	5%	₹51 Cr	270,000 ↑ 15,000
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 28 Feb 18 \| DRREDDY	4%	₹45 Cr	360,000
Procter & Gamble Health Ltd (Healthcare) Equity, Since 31 Dec 20 \| PGHL	4%	₹45 Cr	70,039 ↓ -10,244
Fortis Healthcare Ltd (Healthcare) Equity, Since 31 Dec 20 \| FORTIS	4%	₹42 Cr	465,000
Glenmark Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Mar 24 \| GLENMARK	4%	₹42 Cr	220,000 ↑ 30,000
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Apr 21 \| APOLLOHOSP	4%	₹40 Cr	53,000
Alkem Laboratories Ltd (Healthcare) Equity, Since 31 May 21 \| ALKEM	3%	₹38 Cr	72,000 ↑ 17,000

7. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

Research Highlights for SBI Healthcare Opportunities Fund

Upper mid AUM (₹3,963 Cr).
Established history (20+ yrs).
Rating: 2★ (upper mid).
Risk profile: High.
5Y return: 19.36% (bottom quartile).
3Y return: 25.73% (lower mid).
1Y return: 3.00% (top quartile).
Alpha: 2.04 (upper mid).
Sharpe: -0.05 (top quartile).
Information ratio: 0.38 (upper mid).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~96%).
High-quality debt (AAA/AA ~100%).
Largest holding Sun Pharmaceuticals Industries Ltd (~10.9%).

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund Growth
Launch Date	31 Dec 04
NAV (16 Oct 25)	₹435.752 ↑ 2.45 (0.57 %)
Net Assets (Cr)	₹3,963 on 31 Aug 25
Category	Equity - Sectoral
AMC	SBI Funds Management Private Limited
Rating	☆☆
Risk	High
Expense Ratio	1.97
Sharpe Ratio	-0.05
Information Ratio	0.38
Alpha Ratio	2.04
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Sep 20	₹10,000
30 Sep 21	₹13,138
30 Sep 22	₹12,251
30 Sep 23	₹15,800
30 Sep 24	₹23,614
30 Sep 25	₹23,646

SBI Healthcare Opportunities Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹493,520.
Net Profit of ₹193,520 Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 17 Oct 25

Duration	Returns
1 Month	0.3%
3 Month	-1.1%
6 Month	6.4%
1 Year	3%
3 Year	25.7%
5 Year	19.4%
10 Year
15 Year
Since launch	15.4%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	42.2%
2023	38.2%
2022	-6%
2021	20.1%
2020	65.8%
2019	-0.5%
2018	-9.9%
2017	2.1%
2016	-14%
2015	27.1%

Fund Manager information for SBI Healthcare Opportunities Fund

Name	Since	Tenure
Tanmaya Desai	1 Jun 11	14.26 Yr.

Data below for SBI Healthcare Opportunities Fund as on 31 Aug 25

Equity Sector Allocation

Sector	Value
Health Care	90.36%
Basic Materials	5.79%

Asset Allocation

Asset Class	Value
Cash	3.85%
Equity	96.15%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Dec 17 \| SUNPHARMA	11%	₹431 Cr	2,700,000
Divi's Laboratories Ltd (Healthcare) Equity, Since 31 Mar 12 \| DIVISLAB	7%	₹270 Cr	440,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 21 \| 543220	6%	₹242 Cr	2,100,000
Cipla Ltd (Healthcare) Equity, Since 31 Aug 16 \| CIPLA	5%	₹191 Cr	1,200,000
Lonza Group Ltd ADR (Healthcare) Equity, Since 31 Jan 24 \| LO3A	4%	₹168 Cr	270,000
Lupin Ltd (Healthcare) Equity, Since 31 Aug 23 \| LUPIN	4%	₹159 Cr	840,000
Torrent Pharmaceuticals Ltd (Healthcare) Equity, Since 30 Jun 21 \| TORNTPHARM	4%	₹142 Cr	400,000 ↑ 80,000
Mankind Pharma Ltd (Healthcare) Equity, Since 30 Apr 23 \| MANKIND	3%	₹138 Cr	560,000
Fortis Healthcare Ltd (Healthcare) Equity, Since 30 Apr 21 \| FORTIS	3%	₹137 Cr	1,500,000
Gland Pharma Ltd (Healthcare) Equity, Since 30 Nov 20 \| GLAND	3%	₹131 Cr	700,000

8. TATA India Pharma & Healthcare Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

Research Highlights for TATA India Pharma & Healthcare Fund

Lower mid AUM (₹1,309 Cr).
Established history (9+ yrs).
Not Rated.
Risk profile: High.
5Y return: 17.80% (bottom quartile).
3Y return: 22.90% (bottom quartile).
1Y return: -0.05% (upper mid).
Alpha: 3.78 (upper mid).
Sharpe: -0.39 (lower mid).
Information ratio: 0.78 (upper mid).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~97%).
Largest holding Sun Pharmaceuticals Industries Ltd (~9.9%).

Below is the key information for TATA India Pharma & Healthcare Fund

TATA India Pharma & Healthcare Fund Growth
Launch Date	28 Dec 15
NAV (17 Oct 25)	₹30.9955 ↑ 0.17 (0.56 %)
Net Assets (Cr)	₹1,309 on 31 Aug 25
Category	Equity - Sectoral
AMC	Tata Asset Management Limited
Rating	Not Rated
Risk	High
Expense Ratio	2.17
Sharpe Ratio	-0.39
Information Ratio	0.78
Alpha Ratio	3.78
Min Investment	5,000
Min SIP Investment	150
Exit Load	0-3 Months (0.25%),3 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Sep 20	₹10,000
30 Sep 21	₹13,118
30 Sep 22	₹12,243
30 Sep 23	₹14,936
30 Sep 24	₹22,907
30 Sep 25	₹22,051

TATA India Pharma & Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹470,047.
Net Profit of ₹170,047 Invest Now

Returns for TATA India Pharma & Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 17 Oct 25

Duration	Returns
1 Month	0.3%
3 Month	0.1%
6 Month	7.1%
1 Year	-0.1%
3 Year	22.9%
5 Year	17.8%
10 Year
15 Year
Since launch	12.2%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	40.4%
2023	36.6%
2022	-8%
2021	19.1%
2020	64.4%
2019	5.5%
2018	-2.6%
2017	4.7%
2016	-14.7%
2015

Fund Manager information for TATA India Pharma & Healthcare Fund

Name	Since	Tenure
Rajat Srivastava	16 Sep 24	0.96 Yr.

Data below for TATA India Pharma & Healthcare Fund as on 31 Aug 25

Equity Sector Allocation

Sector	Value
Health Care	94.45%
Financial Services	1.56%
Basic Materials	1.44%

Asset Allocation

Asset Class	Value
Cash	2.56%
Equity	97.44%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Jan 16 \| SUNPHARMA	10%	₹130 Cr	815,483 ↓ -40,979
Cipla Ltd (Healthcare) Equity, Since 30 Apr 20 \| CIPLA	7%	₹91 Cr	569,903
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 31 Dec 16 \| APOLLOHOSP	5%	₹67 Cr	88,528 ↓ -4,298
HealthCare Global Enterprises Ltd (Healthcare) Equity, Since 31 Dec 18 \| HCG	5%	₹63 Cr	942,453
Lupin Ltd (Healthcare) Equity, Since 30 Nov 17 \| LUPIN	5%	₹63 Cr	330,887
Torrent Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Aug 22 \| TORNTPHARM	5%	₹60 Cr	168,394 ↑ 13,677
Aster DM Healthcare Ltd Ordinary Shares (Healthcare) Equity, Since 31 Dec 22 \| ASTERDM	4%	₹58 Cr	956,991
Alkem Laboratories Ltd (Healthcare) Equity, Since 31 Aug 20 \| ALKEM	4%	₹56 Cr	106,435
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Jul 25 \| 543220	4%	₹53 Cr	458,724 ↑ 50,807
Divi's Laboratories Ltd (Healthcare) Equity, Since 30 Sep 17 \| DIVISLAB	4%	₹51 Cr	83,315 ↑ 21,175

9. IDBI Small Cap Fund

The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However there can be no assurance that the investment objective under the Scheme will be realized.

Research Highlights for IDBI Small Cap Fund

Bottom quartile AUM (₹604 Cr).
Established history (8+ yrs).
Not Rated.
Risk profile: Moderately High.
5Y return: 27.67% (upper mid).
3Y return: 17.82% (bottom quartile).
1Y return: -10.44% (bottom quartile).
Alpha: -4.61 (bottom quartile).
Sharpe: -0.70 (bottom quartile).
Information ratio: -0.82 (bottom quartile).
Top sector: Industrials.
Higher exposure to Cash Equivalent (bond sector) vs peer median.
Equity-heavy allocation (~92%).
Largest holding Apollo Micro Systems Ltd Ordinary Shares (~3.4%).

Below is the key information for IDBI Small Cap Fund

IDBI Small Cap Fund Growth
Launch Date	21 Jun 17
NAV (17 Oct 25)	₹30.323 ↓ -0.16 (-0.51 %)
Net Assets (Cr)	₹604 on 31 Aug 25
Category	Equity - Small Cap
AMC	IDBI Asset Management Limited
Rating	Not Rated
Risk	Moderately High
Expense Ratio	2.3
Sharpe Ratio	-0.7
Information Ratio	-0.82
Alpha Ratio	-4.61
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Sep 20	₹10,000
30 Sep 21	₹18,099
30 Sep 22	₹20,385
30 Sep 23	₹24,177
30 Sep 24	₹37,333
30 Sep 25	₹33,001

IDBI Small Cap Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹598,181.
Net Profit of ₹298,181 Invest Now

Returns for IDBI Small Cap Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 17 Oct 25

Duration	Returns
1 Month	-3.5%
3 Month	-3.9%
6 Month	6.6%
1 Year	-10.4%
3 Year	17.8%
5 Year	27.7%
10 Year
15 Year
Since launch	14.3%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	40%
2023	33.4%
2022	2.4%
2021	64.7%
2020	19%
2019	-4.4%
2018	-15%
2017
2016
2015

Fund Manager information for IDBI Small Cap Fund

Name	Since	Tenure
Nikhil Rungta	1 Jul 24	1.17 Yr.
Mahesh Bendre	1 Jul 24	1.17 Yr.

Data below for IDBI Small Cap Fund as on 31 Aug 25

Equity Sector Allocation

Sector	Value
Industrials	32.4%
Basic Materials	13.71%
Consumer Cyclical	12.58%
Consumer Defensive	7.42%
Financial Services	6.62%
Technology	6.3%
Utility	5.99%
Health Care	5.53%
Communication Services	1.75%

Asset Allocation

Asset Class	Value
Cash	7.72%
Equity	92.29%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Apollo Micro Systems Ltd Ordinary Shares (Industrials) Equity, Since 30 Jun 25 \| 540879	3%	₹21 Cr	877,192
Allied Blenders and Distillers Ltd (Consumer Defensive) Equity, Since 31 Jul 24 \| ABDL	3%	₹16 Cr	326,140
Manorama Industries Ltd (Consumer Defensive) Equity, Since 31 Dec 24 \| 541974	2%	₹15 Cr	109,106
Concord Enviro Systems Ltd (Utilities) Equity, Since 31 Dec 24 \| CEWATER	2%	₹15 Cr	270,441
JTL Industries Ltd (Basic Materials) Equity, Since 31 Jul 24 \| 534600	2%	₹14 Cr	1,958,225 ↓ -165,804
Housing & Urban Development Corp Ltd (Financial Services) Equity, Since 31 Oct 24 \| HUDCO	2%	₹14 Cr	668,754
Syrma SGS Technology Ltd (Technology) Equity, Since 31 May 25 \| SYRMA	2%	₹14 Cr	180,780
Arvind Fashions Ltd (Consumer Cyclical) Equity, Since 29 Feb 24 \| ARVINDFASN	2%	₹13 Cr	259,739
Navkar Corp Ltd (Industrials) Equity, Since 31 Jul 24 \| NAVKARCORP	2%	₹13 Cr	1,130,075
Exide Industries Ltd (Consumer Cyclical) Equity, Since 31 Dec 24 \| EXIDEIND	2%	₹13 Cr	321,398

10. Bandhan Infrastructure Fund

The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized.

Research Highlights for Bandhan Infrastructure Fund

Lower mid AUM (₹1,613 Cr).
Established history (14+ yrs).
Rating: 5★ (top quartile).
Risk profile: High.
5Y return: 33.39% (top quartile).
3Y return: 27.74% (upper mid).
1Y return: -8.68% (bottom quartile).
Alpha: 0.00 (bottom quartile).
Sharpe: -0.71 (bottom quartile).
Information ratio: 0.00 (bottom quartile).
Higher exposure to Industrials vs peer median.
Higher exposure to Cash Equivalent (bond sector) vs peer median.
Equity-heavy allocation (~91%).
Largest holding Kirloskar Brothers Ltd (~5.2%).

Below is the key information for Bandhan Infrastructure Fund

Bandhan Infrastructure Fund Growth
Launch Date	8 Mar 11
NAV (17 Oct 25)	₹49.783 ↓ -0.13 (-0.25 %)
Net Assets (Cr)	₹1,613 on 31 Aug 25
Category	Equity - Sectoral
AMC	IDFC Asset Management Company Limited
Rating	☆☆☆☆☆
Risk	High
Expense Ratio	2.1
Sharpe Ratio	-0.71
Information Ratio	0
Alpha Ratio	0
Min Investment	5,000
Min SIP Investment	100
Exit Load	0-365 Days (1%),365 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Sep 20	₹10,000
30 Sep 21	₹20,085
30 Sep 22	₹20,588
30 Sep 23	₹27,745
30 Sep 24	₹47,816
30 Sep 25	₹41,763

Bandhan Infrastructure Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹689,048.
Net Profit of ₹389,048 Invest Now

Returns for Bandhan Infrastructure Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 17 Oct 25

Duration	Returns
1 Month	-2.2%
3 Month	-3.8%
6 Month	5.9%
1 Year	-8.7%
3 Year	27.7%
5 Year	33.4%
10 Year
15 Year
Since launch	11.6%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	39.3%
2023	50.3%
2022	1.7%
2021	64.8%
2020	6.3%
2019	-5.3%
2018	-25.9%
2017	58.7%
2016	10.7%
2015	-0.2%

Fund Manager information for Bandhan Infrastructure Fund

Name	Since	Tenure
Vishal Biraia	24 Jan 24	1.6 Yr.
Ritika Behera	7 Oct 23	1.9 Yr.
Gaurav Satra	7 Jun 24	1.24 Yr.

Data below for Bandhan Infrastructure Fund as on 31 Aug 25

Equity Sector Allocation

Sector	Value
Industrials	53.39%
Utility	12.18%
Basic Materials	7.23%
Communication Services	4.6%
Energy	3.81%
Financial Services	3.12%
Health Care	2.24%
Technology	2.22%
Consumer Cyclical	1.38%
Real Estate	1.2%

Asset Allocation

Asset Class	Value
Cash	8.64%
Equity	91.36%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Kirloskar Brothers Ltd (Industrials) Equity, Since 31 Dec 17 \| KIRLOSBROS	5%	₹84 Cr	433,186 ↓ -10,199
Larsen & Toubro Ltd (Industrials) Equity, Since 29 Feb 12 \| LT	5%	₹74 Cr	206,262
UltraTech Cement Ltd (Basic Materials) Equity, Since 31 Mar 14 \| ULTRACEMCO	4%	₹63 Cr	49,772
Bharti Airtel Ltd (Communication Services) Equity, Since 30 Apr 19 \| BHARTIARTL	4%	₹62 Cr	330,018
Reliance Industries Ltd (Energy) Equity, Since 30 Jun 24 \| RELIANCE	4%	₹61 Cr	452,706
Bharat Electronics Ltd (Industrials) Equity, Since 31 Oct 19 \| BEL	3%	₹53 Cr	1,431,700
GPT Infraprojects Ltd (Industrials) Equity, Since 30 Nov 17 \| GPTINFRA	3%	₹53 Cr	4,733,244
Adani Ports & Special Economic Zone Ltd (Industrials) Equity, Since 31 Dec 23 \| ADANIPORTS	3%	₹48 Cr	365,137
InterGlobe Aviation Ltd (Industrials) Equity, Since 31 Aug 24 \| INDIGO	3%	₹47 Cr	83,887 ↑ 34,446
PTC India Financial Services Ltd (Financial Services) Equity, Since 31 Dec 23 \| PFS	3%	₹47 Cr	12,400,122

Disclaimer:
ഇവിടെ നൽകിയിരിക്കുന്ന വിവരങ്ങൾ കൃത്യമാണെന്ന് ഉറപ്പാക്കാൻ എല്ലാ ശ്രമങ്ങളും നടത്തി. എന്നിരുന്നാലും, ഡാറ്റയുടെ കൃത്യത സംബന്ധിച്ച് ഒരു ഉറപ്പുമില്ല. നിക്ഷേപം നടത്തുന്നതിന് മുമ്പ് ദയവായി സ്കീം വിവര പ്രമാണം ഉപയോഗിച്ച് പരിശോധിക്കുക.